Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Sulfuric acid, iron(2+) salt (1:?)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 Dr. Paul Lohmann GmbH KG
    Germany
    		 DR. PAUL LOHMANN GMBH & CO. KGAA Emmerthal DE R1-CEP 2007-368 - Rev 04 Ferrous sulfate, dried, Powder, milled powder, micronised powder 2022-01-28 Valid Chemical 2340
    29/11/2025 Dr. Paul Lohmann GmbH KG
    Germany
    		 DR. PAUL LOHMANN GMBH & CO. KGAA Emmerthal DE R1-CEP 2007-369 - Rev 03 Ferrous sulfate heptahydrate 2022-02-01 Valid Chemical 83